FIORENTINI, ALESSIO
FIORENTINI, ALESSIO
Universita' degli Studi di MILANO
Transition Between Sensitive Delusion of Reference and Mood Disorder : A Case Report
2021 C.M. Esposito, A. Fiorentini, A. Callari, G.M. Galeazzi, P. Brambilla
Impact of the first Covid-19 pandemic wave on first episode psychosis in Milan, italy
2021 C.M. Esposito, A. D'Agostino, B. Dell Osso, A. Fiorentini, C. Prunas, A. Callari, L. Oldani, E. Fontana, G. Gargano, B. Viscardi, B. Giordano, S. D'Angelo, F. Wiedenmann, M. Macellaro, F. Giorgetti, N. Turtulici, O. Gambini, P. Brambilla
Psychomotor Agitation Non-responsive to Treatment: A Case Report of Phenibut Withdrawal Syndrome
2021 C.M. Esposito, G.M. Mandolini, G. Delvecchio, A. Fiorentini, P. Brambilla
Substance-induced psychoses : an updated literature review
2021 A. Fiorentini, F. Cantù, C. Crisanti, G. Cereda, L. Oldani, P. Brambilla
Diogenes syndrome in dementia: a case report
2021 L. Sacchi, E. Rotondo, S. Pozzoli, A. Fiorentini, G. Schinco, C. Mandelli, C. Coppola, G.G. Fumagalli, T. Carandini, A.M. Pietroboni, D. Galimberti, F. Triulzi, G. Marotta, E. Scarpini, M. Cesari, P. Brambilla, A. Arighi
Case Report: The Association Between Chromosomal Anomalies and Cluster A Personality Disorders: The Case of Two Siblings With 16p11.2 Deletion and a Review of the Literature
2021 C.M. Esposito, P. Enrico, D. Sciortino, E. Caletti, G.B. Marchetti, C. Cesaretti, L. Oldani, A. Fiorentini, P. Brambilla
Pharmacokinetics of antidepressants in patients with hepatic impairment
2014 M. Mauri, A. Fiorentini, S. Paletta, A. Altamura
Neuropsychology, social cognition and global functioning among bipolar, schizophrenic patients and healthy controls: preliminary data
2013 E. Caletti, R. Paoli, A. Fiorentini, M. Cigliobianco, E. Zugno, M. Serati, G. Orsenigo, P. Grillo, S. Zago, A. Caldiroli, C. Prunas, F. Giusti, D. Consonni, A. Altamura
Substance-induced psychoses : a critical review of the literature
2011 A. Fiorentini, L.S. Volonteri, F. Dragogna, C. Rovera, M. Maffini, M.C. Mauri, A.C. Altamura
Clinical outcome and tolerability of duloxetine in the treatment of major depressive disorder: a 12-week study with plasma levels.
2010 L.S. Volonteri, A. Colasanti, G. Cerveri, A. Fiorentini, I.F. De Gaspari, M.C. Mauri, A. Valli, P. Papa, C. Mencacci
Two weeks’ quetiapine treatment for schizophrenia, drug-induced psychosis and borderline personality disorder : a naturalistic study with drug plasma levels
2007 M.C. Mauri, L.S. Volonteri, A. Fiorentini, R. Pirola, S.R. Bareggi